Molecular evolution of a peptide GPCR ligand driven by artificial neural networks.

Peptide ligands of G protein-coupled receptors constitute valuable natural lead structures for the development of highly selective drugs and high-affinity tools to probe ligand-receptor interaction. Currently, pharmacological and metabolic modification of natural peptides involves either an iterativ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sebastian Bandholtz, Jörg Wichard, Ronald Kühne, Carsten Grötzinger
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0805680bab184e97b215ad6c2f0cb4f2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0805680bab184e97b215ad6c2f0cb4f2
record_format dspace
spelling oai:doaj.org-article:0805680bab184e97b215ad6c2f0cb4f22021-11-18T07:18:54ZMolecular evolution of a peptide GPCR ligand driven by artificial neural networks.1932-620310.1371/journal.pone.0036948https://doaj.org/article/0805680bab184e97b215ad6c2f0cb4f22012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22606313/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Peptide ligands of G protein-coupled receptors constitute valuable natural lead structures for the development of highly selective drugs and high-affinity tools to probe ligand-receptor interaction. Currently, pharmacological and metabolic modification of natural peptides involves either an iterative trial-and-error process based on structure-activity relationships or screening of peptide libraries that contain many structural variants of the native molecule. Here, we present a novel neural network architecture for the improvement of metabolic stability without loss of bioactivity. In this approach the peptide sequence determines the topology of the neural network and each cell corresponds one-to-one to a single amino acid of the peptide chain. Using a training set, the learning algorithm calculated weights for each cell. The resulting network calculated the fitness function in a genetic algorithm to explore the virtual space of all possible peptides. The network training was based on gradient descent techniques which rely on the efficient calculation of the gradient by back-propagation. After three consecutive cycles of sequence design by the neural network, peptide synthesis and bioassay this new approach yielded a ligand with 70fold higher metabolic stability compared to the wild type peptide without loss of the subnanomolar activity in the biological assay. Combining specialized neural networks with an exploration of the combinatorial amino acid sequence space by genetic algorithms represents a novel rational strategy for peptide design and optimization.Sebastian BandholtzJörg WichardRonald KühneCarsten GrötzingerPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 5, p e36948 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sebastian Bandholtz
Jörg Wichard
Ronald Kühne
Carsten Grötzinger
Molecular evolution of a peptide GPCR ligand driven by artificial neural networks.
description Peptide ligands of G protein-coupled receptors constitute valuable natural lead structures for the development of highly selective drugs and high-affinity tools to probe ligand-receptor interaction. Currently, pharmacological and metabolic modification of natural peptides involves either an iterative trial-and-error process based on structure-activity relationships or screening of peptide libraries that contain many structural variants of the native molecule. Here, we present a novel neural network architecture for the improvement of metabolic stability without loss of bioactivity. In this approach the peptide sequence determines the topology of the neural network and each cell corresponds one-to-one to a single amino acid of the peptide chain. Using a training set, the learning algorithm calculated weights for each cell. The resulting network calculated the fitness function in a genetic algorithm to explore the virtual space of all possible peptides. The network training was based on gradient descent techniques which rely on the efficient calculation of the gradient by back-propagation. After three consecutive cycles of sequence design by the neural network, peptide synthesis and bioassay this new approach yielded a ligand with 70fold higher metabolic stability compared to the wild type peptide without loss of the subnanomolar activity in the biological assay. Combining specialized neural networks with an exploration of the combinatorial amino acid sequence space by genetic algorithms represents a novel rational strategy for peptide design and optimization.
format article
author Sebastian Bandholtz
Jörg Wichard
Ronald Kühne
Carsten Grötzinger
author_facet Sebastian Bandholtz
Jörg Wichard
Ronald Kühne
Carsten Grötzinger
author_sort Sebastian Bandholtz
title Molecular evolution of a peptide GPCR ligand driven by artificial neural networks.
title_short Molecular evolution of a peptide GPCR ligand driven by artificial neural networks.
title_full Molecular evolution of a peptide GPCR ligand driven by artificial neural networks.
title_fullStr Molecular evolution of a peptide GPCR ligand driven by artificial neural networks.
title_full_unstemmed Molecular evolution of a peptide GPCR ligand driven by artificial neural networks.
title_sort molecular evolution of a peptide gpcr ligand driven by artificial neural networks.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/0805680bab184e97b215ad6c2f0cb4f2
work_keys_str_mv AT sebastianbandholtz molecularevolutionofapeptidegpcrliganddrivenbyartificialneuralnetworks
AT jorgwichard molecularevolutionofapeptidegpcrliganddrivenbyartificialneuralnetworks
AT ronaldkuhne molecularevolutionofapeptidegpcrliganddrivenbyartificialneuralnetworks
AT carstengrotzinger molecularevolutionofapeptidegpcrliganddrivenbyartificialneuralnetworks
_version_ 1718423577556942848